BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16341093)

  • 1. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.
    Brenner D; Golks A; Kiefer F; Krammer PH; Arnold R
    EMBO J; 2005 Dec; 24(24):4279-90. PubMed ID: 16341093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells.
    Brenner D; Brechmann M; Röhling S; Tapernoux M; Mock T; Winter D; Lehmann WD; Kiefer F; Thome M; Krammer PH; Arnold R
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14508-13. PubMed ID: 19706536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes.
    Brenner D; Golks A; Becker M; Müller W; Frey CR; Novak R; Melamed D; Kiefer F; Krammer PH; Arnold R
    Blood; 2007 Dec; 110(12):3968-77. PubMed ID: 17712048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
    Arnold R; Patzak IM; Neuhaus B; Vancauwenbergh S; Veillette A; Van Lint J; Kiefer F
    Mol Cell Biol; 2005 Mar; 25(6):2364-83. PubMed ID: 15743830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts of activated T cell death.
    Brenner D; Krammer PH; Arnold R
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):52-64. PubMed ID: 18289867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD).
    Gudi R; Barkinge J; Hawkins S; Chu F; Manicassamy S; Sun Z; Duke-Cohan JS; Prasad KV
    Oncogene; 2006 Jun; 25(24):3458-62. PubMed ID: 16491128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion.
    Patzak IM; Königsberger S; Suzuki A; Mak TW; Kiefer F
    Eur J Immunol; 2010 Nov; 40(11):3220-5. PubMed ID: 20957749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling.
    Ling P; Meyer CF; Redmond LP; Shui JW; Davis B; Rich RR; Hu MC; Wange RL; Tan TH
    J Biol Chem; 2001 Jun; 276(22):18908-14. PubMed ID: 11279207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation.
    Arnold R; Frey CR; Müller W; Brenner D; Krammer PH; Kiefer F
    Cell Death Differ; 2007 Mar; 14(3):568-75. PubMed ID: 17024227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
    Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
    Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes.
    Ma W; Xia C; Ling P; Qiu M; Luo Y; Tan TH; Liu M
    Oncogene; 2001 Mar; 20(14):1703-14. PubMed ID: 11313918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses.
    Shui JW; Boomer JS; Han J; Xu J; Dement GA; Zhou G; Tan TH
    Nat Immunol; 2007 Jan; 8(1):84-91. PubMed ID: 17115060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
    Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of Sprouty1 to immune synapse regulates T cell receptor signaling.
    Lee JS; Lee JE; Oh YM; Park JB; Choi H; Choi CY; Kim IH; Lee SH; Choi K
    J Immunol; 2009 Dec; 183(11):7178-86. PubMed ID: 19915061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
    Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
    Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20.
    Malewicz M; Zeller N; Yilmaz ZB; Weih F
    J Biol Chem; 2003 Aug; 278(35):32825-33. PubMed ID: 12813034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis.
    Di Somma MM; Somma F; Gilardini Montani MS; Mangiacasale R; Cundari E; Piccolella E
    J Immunol; 1999 Apr; 162(7):3851-8. PubMed ID: 10201902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
    Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T
    Eur J Immunol; 1997 Aug; 27(8):1858-64. PubMed ID: 9295019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.